This fusion protein was characterized in T-cell acute lymphoblastic leukemia (T-ALL) patients, which constitutively activated JAK2 tyrosine kinase activity, STAT phosphorylation and conferred cytokine-independent T-ALL cell proliferation [33,34]. The gene discussed is JAK2; the disease is acute lymphoblastic leukemia.